SARON

Trial description
Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer. A randomised phase III trial
Contact name
Dr Susan Harden
Trial start date
Wednesday, August 9, 2017
Trial end date
Tuesday, July 4, 2023
Trial tumour type
Lung
Show on Radiotherapy
Yes